Study of Online Cognitive Training to Improve Brain Function in Adults After Hematopoietic Cell Transplant

What this Trial Is About

Researchers are evaluating the feasibility of enrolling patients who have undergone hematopoietic cell transplantation HCT to improve their neurocognitive function using the Lumosity cognitive training program. This pilot study also aims to assess patients interest in receiving genetic risk information related to cognitive impairment after HCT. Understanding patient preferences regarding genetic risk communication is important as personalized medicine advances. The study uses the Lumosity program, an online cognitive training tool with over 60 game-like tasks targeting processing speed, working memory, and executive function. Participants will engage in daily sessions of five training tasks for 12 weeks. The study has two groups one starts the Lumosity program immediately upon enrollment, while the other begins after a 3-month waiting period. Customized performance reports are generated each time participants complete a session. Participants will be monitored over 12 weeks to measure cognitive function changes between the two groups. Surveys will assess genetic knowledge and attitudes toward receiving genetic risk information. Data collection includes cognitive performance reports and questionnaires on genetic understanding, the importance of genetic information, and its impact on intervention uptake and adherence. The studys total participation duration is 12 weeks.

Cognitive Training Intervention and Attitudes Towards Genetics